T. Zoega

发表

Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.

R. Crowe, T. Kato, Z. Wang, 1996, American journal of medical genetics.

An international two–stage genome–wide search for schizophrenia susceptibility genes

J. Weissenbach, K. Kidd, A. Pakstis, 1995, Nature Genetics.

The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

I. Gottesman, H. Moises, T. Zoega, 2002, BMC psychiatry.

Neuregulin 1 strongly implicated as susceptibility gene for schizophrenia by allelic association study

I. Gottesman, Liu Yang, P. Matthiasson, 2002, cond-mat/0203527.

No evidence of linkage between schizophrenia and D3 dopamine receptor gene locus in Icelandic pedigrees

P. Sokoloff, J. Schwartz, L. Lannfelt, 1993, Psychiatry Research.

Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder.

R. Noyes, R. Crowe, Z. Wang, 1998, American journal of medical genetics.

Antidepressants and public health in Iceland Antidepressants and public health in Iceland Time series analysis of national data Time series analysis of national data

H. Tómasson, T. Helgason, T. Zoega, 2004 .

Background Majordepressive disorder is the second leadingcause of disability-adjusted life-years in developed regions oftheworld and antidepressants are the third-ranking therapyclass

T. Helgason, T. Zoega, 2004 .

A mutation in the cholecystokinin gene (cck-36c→t) is a candidate mutation for panic disorder

R. Noyes, R. Crowe, Zhewu Wang, 1996 .